Rebecca Chambers, the Chief Financial Officer of Veracyte, has executed a sale of company stock valued at $177,082. This transaction was disclosed in a filing with the Securities and Exchange Commission. The sale reflects Chambers' ongoing management of her investment portfolio, consistent with company policies regarding stock transactions.
Related Articles
Don't miss out on breaking stories and in-depth articles.